Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 07, 2023 13:00 ET | Source: DelveInsight Business Research LLP

Acute Myeloid Leukemia Market Size and Share to Rise by 2032, Predicts DelveInsight | Key Companies - Chimerix, GlycoMimetics, Arog, Delta-Fly, Jasper, Jazz, Daiichi Sankyo, Amgen, AbbVie, Merck, Eli Lilly

New York, USA, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Acute Myeloid Leukemia Market Size and Share to Rise by 2032, Predicts DelveInsight | Key Companies - Chimerix, GlycoMimetics, Arog, Delta-Fly,...
September 06, 2022 13:00 ET | Source: DelveInsight Business Research LLP

Relapsed/Refractory Acute Myeloid Leukemia Pipeline Analysis: 60+ Leading Companies are Working to Improve the Treatment Landscape

New York, USA, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Relapsed/Refractory Acute Myeloid Leukemia Pipeline Analysis: 60+ Leading Companies are Working to Improve the Treatment Landscape DelveInsight’s...
July 14, 2022 08:15 ET | Source: GlobalData Plc

AbbVie/Roche’s Venclexta is Set to Remain the Acute Myeloid Leukemia Drugs Market Leader | GlobalData Plc

LONDON, July 14, 2022 (GLOBE NEWSWIRE) -- The “Acute Myeloid Leukemia (AML) – Opportunity Analysis and Forecasts to 2029” report offered by GlobalData provides an overview of AML including...
February 15, 2021 20:00 ET | Source: DelveInsight Business Research LLP

Acute Myeloid Leukemia Pipeline Assessment 2021 report covers Unmet Needs, Key Opportunities, and Major Players

Los Angeles, USA, Feb. 15, 2021 (GLOBE NEWSWIRE) -- Acute Myeloid Leukemia Pipeline Assessment 2021 report covers Unmet Needs, Key Opportunities, and Major Players DelveInsight highlights recent...